Downregulation of miR-205 contributes to epithelial–mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1–RAGE signaling pathway
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000705
Identification of oncogenic long noncoding RNAs CASC9 and LINC00152 in oral carcinoma through genome-wide comprehensive analysis
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000725
Sinensetin induces apoptosis and autophagy in the treatment of human T-cell lymphoma
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000756
Methylxanthine derivatives promote autophagy in gastric cancer cells targeting PTEN
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000724
Talazoparib has no clinically relevant effect on QTc interval in patients with advanced solid tumors
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000772
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000730
Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000777
Proapoptotic effects of novel thiazole derivative on human glioma cells
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000686
An autophagy-dependent cell death of MDA-MB-231 cells triggered by a novel Rhein derivative 4F.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000820
Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000779
Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000696
Bacillomycin D-C16 triggers apoptosis of gastric cancer cells through the PI3K/Akt and FoxO3a signaling pathways
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000688
Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000758
Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000781
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000808
Heterocyclic organobismuth(III) compound induces nonapoptotic cell death via lipid peroxidation.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000841
Pyrimethamine exerts significant antitumor effects on human ovarian cancer cells both in vitro and in vivo
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000740
Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000845
Tumor lysis syndrome associated with bortezomib: A post-hoc analysis after signal detection using the US Food and Drug Administration Adverse Event Reporting System
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000862
Tumour flare reaction in cancer treatments: a comprehensive literature review
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000814
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000794
C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000783
Evaluation of the antileukemic effects of neurokinin-1 receptor antagonists, aprepitant, and L-733,060, in chronic and acute myeloid leukemic cells.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000769
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000791
Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000815
Myeloablative chemotherapy and autologous stem cell transplantation can lead to successful postengraftment mobilization of hematopoietic progenitors to support planned subsequent cycle(s) of high-dose chemotherapy and autografting in a patient with relapsed germ-cell tumor
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000714
Monoclonal antibody utilization characteristics in patients with multiple myeloma.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000810
Poor expression of long-chain noncoding RNA GAPLINC inhibits epithelial-mesenchymal transition, and invasion and migration of hepatocellular carcinoma cells.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000752
Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000735
Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000692
Baicalin induces apoptosis in SW480 cells through downregulation of the SP1 transcription factor
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000708
The signaling axis of Rac1-TFEB regulates autophagy and tumorigenesis.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000816
MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000680
A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000788
Methotrexate-induced senescence of human colon cancer cells depends on p53 acetylation, but not genomic aberrations
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000731
Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000762
Partial response in hairy cell leukemia with vemurafenib despite early discontinuation due to agranulocytosis.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000821
Poly (ADP-ribose) polymerase inhibitors combined with other small-molecular compounds for the treatment of ovarian cancer.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000793
Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000828
Synergistic anti-tumour effects of Clostridium butyricum in combination with apatinib in CT26 colorectal tumour-bearing mice.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000817
Effect of miR-196a inhibition on esophageal cancer growth in vitro
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000823
MiR-361-5p exerts tumor-suppressing functions in gastric carcinoma by targeting syndecan-binding protein
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000846
The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000843
Beclin1 affected by DN604 upregulates chemo-sensitivity of cervix SiHa cancer cells via inhibiting CK2-MRN-DSBs repair.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000804
A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette–Guérin immunotherapy
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000775
The frequency and predictors of persistent amenorrhea in premenopausal women with colorectal cancer who received adjuvant chemotherapy
来源期刊:Anti-Cancer DrugsDOI:10.1097/CAD.0000000000000728
Hyperprogression after first dose of immunotherapy in a patient with radioresistant metastasis from nonsmall cell lung cancer.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000837
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000761
Leukocytoclastic vasculitis associated with sorafenib treatment for hepatocellular carcinoma.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000840
Proanthocyanidins attenuate breast cancer-induced bone metastasis by inhibiting Irf-3/c-jun activation.
来源期刊:Anti-cancer drugsDOI:10.1097/CAD.0000000000000852